Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Halothane hepatitis.

Literature DB >> 4930157

Halothane hepatitis.

S Sherlock.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1971 PMID： 4930157 PMCID： PMC1411625 DOI： 10.1136/gut.12.4.324

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

22 in total

1. Hepatitis-associated antigen in chronic liver disease.

Authors: R A Fox; S P Niazi; S Sherlock
Journal: Lancet Date: 1969-09-20 Impact factor: 79.321

2. Antimitochondrial antibodies in jaundice following drug administration.

Authors: M Rodriguez; F Paronetto; F Schaffner; H Popper
Journal: JAMA Date: 1969-04-07 Impact factor: 56.272

3. Fulminant hepatic failure. Presumable contribution to halothane.

Authors: C Trey; L Lipworth; T C Chalmers; C S Davidson; L S Gottlieb; H Popper; S J Saunders
Journal: N Engl J Med Date: 1968-10-10 Impact factor: 91.245

4. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors: D Doniach; I M Roitt; J G Walker; S Sherlock
Journal: Clin Exp Immunol Date: 1966-07 Impact factor: 4.330

5. Recurrent hepatitis attributable to halothane sensitization in an anesthetist.

Authors: G Klatskin; D V Kimberg
Journal: N Engl J Med Date: 1969-03-06 Impact factor: 91.245

6. Halothane-induced liver damage--an entity.

Authors: B Combes
Journal: N Engl J Med Date: 1969-03-06 Impact factor: 91.245

7. Hepatitis after exposure to halothane.

Authors: F M Klion; F Schaffner; H Popper
Journal: Ann Intern Med Date: 1969-09 Impact factor: 25.391

8. Hepatotoxicity after methoxyflurane administration.

Authors: N C Klein; G H Jeffries
Journal: JAMA Date: 1966-09-19 Impact factor: 56.272

9. Concerning hepatotoxicity of halothane.

Authors: C S Davidson; B Babior; H Popper
Journal: N Engl J Med Date: 1966-12-29 Impact factor: 91.245

10. Metabolism of halothane.

Authors: E H Ohen
Journal: Anesthesiology Date: 1967 Jul-Aug Impact factor: 7.892

14 in total

1. Algorithm for an aggressive diagnostic approach to obstructive jaundice.

Authors: R M Katon; M K Bilbao; J Rsoch
Journal: West J Med Date: 1975-03

2. A comparison of the effects of halothane and other anaesthetic agents on hepato-cellular function in patients submitted to elective operations.

Authors: B Kalow; E Rogoman; F H Sims
Journal: Can Anaesth Soc J Date: 1976-01

Halothane hepatitis.

1. Hepatitis-associated antigen in chronic liver disease.

2. Antimitochondrial antibodies in jaundice following drug administration.

3. Fulminant hepatic failure. Presumable contribution to halothane.

4. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

5. Recurrent hepatitis attributable to halothane sensitization in an anesthetist.

6. Halothane-induced liver damage--an entity.

7. Hepatitis after exposure to halothane.

8. Hepatotoxicity after methoxyflurane administration.

9. Concerning hepatotoxicity of halothane.

10. Metabolism of halothane.

1. Algorithm for an aggressive diagnostic approach to obstructive jaundice.

2. A comparison of the effects of halothane and other anaesthetic agents on hepato-cellular function in patients submitted to elective operations.

3. Elevation of serum xanthine oxidase activity following halothane anesthesia in man.

Review 4. Mechanisms and prediction of drug-induced liver disease.

Review 5. Acute hepatic necrosis and fulminant hepatic failure.

6. Halothane hepatitis: fact or fallacy.

7. Ultrastructural pathology of a case of halothane hepatitis.

8. Hepatotoxicity following enflurane anesthesia.

9. Halothane hepatitis.

10. Jaundice after multiple halothane anaesthetics administered during the treatment of carcinoma of the uterus.